Moomoo AI 已提取核心信息
John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 20, 2024, involving the acquisition of 160 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have increased to a total of 333 shares. The transaction reflects a continued investment in the company by an individual with a remarked relationship to the issuer.
John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 20, 2024, involving the acquisition of 160 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have increased to a total of 333 shares. The transaction reflects a continued investment in the company by an individual with a remarked relationship to the issuer.
与T2 Biosystems, Inc. [TTOO] 相关的约翰·斯佩尔泽尔三世于2024年2月20日执行了一项交易，涉及收购160股普通股。该交易被归类为'M'，表示行使或转换衍生证券。在这笔交易之后，斯佩尔泽尔在T2 Biosystems的直接持股量已增加到总共333股。该交易反映了与发行人有特殊关系的个人对该公司的持续投资。
与T2 Biosystems, Inc. [TTOO] 相关的约翰·斯佩尔泽尔三世于2024年2月20日执行了一项交易，涉及收购160股普通股。该交易被归类为'M'，表示行使或转换衍生证券。在这笔交易之后，斯佩尔泽尔在T2 Biosystems的直接持股量已增加到总共333股。该交易反映了与发行人有特殊关系的个人对该公司的持续投资。
有用
没用
该公告为独立文件：
